Abstract
Background: Patients undergoing gastrectomy require effective parenteral nutritional support in the early postoperative period because of inadequate oral intake. The present study examined the feasibility and efficacy of our new clinical pathway (CP) for gastric cancer surgery including peripheral parenteral nutrition composed of lipids,amino acids and glucose in the early postgastrectomy period.
Patients and Methods: For the perioperative management of gastric cancer surgery, a new CP was used for 94 patients (NCP group), while the conventional clinical pathway was used for 91 patients (CCP group). Completion of the CP, postoperative morbidity, length of postoperative hospital stay, change in body weight and nutritional status were retrospectively reviewed and compared between the two groups.
Results: There were no differences in the completion of the CP, postoperative morbidity and length of postoperative hospital stay between the two groups.We were no serious adverse events in the postoperative nutritional management using the new CP group including the fat emulsion daily administration. The decrease in serum albumin level at 1 month after surgery was significantly smaller in the NCP group than the CCP group.
Conclusions: Our new CP including peripheral parenteral nutrition composed of lipids,amino acids and glucose in the early postoperative period is feasible for the perioperative management of patients after gastric cancer surgery, and would improve postoperative body weight loss and nutritional status.
